Benign, dysplastic, or malignant - Making sense of endoscopic bile duct brush cytology: Results in 149 consecutive patients

J. G. Lee, Joseph Leung, J. Baillie, L. J. Layfield, P. B. Cotton

Research output: Contribution to journalArticle

137 Scopus citations

Abstract

Objectives: To determine the efficacy of endoscopic bile duct brush cytology for diagnosis of pancreaticobiliary malignancies and to provide guidelines for interpretation of dysplastic cytology. Methods: Consecutive endoscopic bile duct brush cytology specimens were classified by an independent cytopathologist as benign, low- or high-grade dysplasia, or cancer. A final diagnosis was established in a blinded fashion by histopathology, radiographic evidence of metastatic disease, or independent clinical follow-up. Sensitivity and specificity were adjusted for dysplastic cytology, and likelihood ratios were determined for each diagnosis and used for calculation of posttest probability of malignancy. Results: Dysplasia was found in 23 % of 168 consecutive bile duct brushings performed in 149 patients. Sensitivity of brush cytology was 37% and specificity 100%; its likelihood ratio for malignancy ranged from 3.4 for high-grade dysplasia, to 1.1 for low- grade dysplasia, to 0.6 for benign. For a patient with a 50% pretest probability of malignancy, finding of high-grade dysplasia changed the posttest probability to 77%, low-grade dysplasia to 52%, and benign to 38%. Conclusion: Cytological dysplasia occurs frequently, with high-grade dysplasia being strongly suggestive of malignancy. Presented likelihood ratios can be used to calculate the posttest probability of malignancy for any diagnosis.

Original languageEnglish (US)
Pages (from-to)722-726
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume90
Issue number5
StatePublished - 1995
Externally publishedYes

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Benign, dysplastic, or malignant - Making sense of endoscopic bile duct brush cytology: Results in 149 consecutive patients'. Together they form a unique fingerprint.

  • Cite this